Home/Theravance Biopharma/Brett Grimaud

BG

Brett Grimaud

Senior Vice President, General Counsel and Secretary

Theravance Biopharma

Therapeutic Areas

Respiratory Chronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Pipeline

Drug	Indication	Phase
YUPELRI® (revefenacin)	COPD (Maintenance Treatment)	Approved
Nebulized LAMA/LABA Combination (TD-0903)	COPD (Maintenance Treatment)	Phase 2
JNJ-64417161 (TD-8236)	Undisclosed Inflammatory Disease	Out-licensed

Leadership Team at Theravance Biopharma

Rick E Winningham

Chief Executive Officer

Rhonda F. Farnum

Senior Vice President, Commercial and Medical Affairs and Chief Business Officer

Laurie Smaldone Alsup

View full Theravance Biopharma profile